1st Quarter - Report

EPILEPSY FOUNDATION for EPILEPSY FOUNDATION

Firm
Client
Income
—
Expenses
$30,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Medicare and Medicaid Related Issues and Prescription Drug Policy Medicare Policy Reform Prescription Drug Access Issues Health Care Reform

LobbyistCovered position, as disclosed
DONNA MELTZER Senior Government Relations Director
ANGELA OSTROM Director, Federal Relations

Contacted: White House Office; Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); SENATE

Veterans VET

Implementation of the VA Epilepsy Centers of Excellence Act

LobbyistCovered position, as disclosed
DONNA MELTZER Director, Federal Relations
ANGELA OSTROM Director, Federal Relations

Contacted: Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); White House Office; HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC)

Budget/Appropriations BUD

Labor, HHS, Education and Related Agencies on epilepsy and health issues. Appropriations for NIH, CDCP, and HRSA, and funding for the Lifespan Respite Act. Research Funding for Epilepsy.

LobbyistCovered position, as disclosed
DONNA MELTZER Senior Government Relations Director
ANGELA OSTROM Director, Federal Relations

Contacted: SENATE; Health Resources & Services Administration (HRSA); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); White House Office; Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.